<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>Carcinoma</title><meta name="description" content="Carcinoma is a malignancy that develops from epithelial cells.^[1] Specifically, a carcinoma is a cancer that begins in a tissue that lines the inner or outer surfaces of the body, and that arises from cells originating in the endodermal, mesodermal or ectodermal germ layer during embryogenesis.^[5] Carcinomas represent 80-90% of all human cancers.^[48] It is from the Greek: καρκίνωμα, romanized: karkinōma, lit. &#x27;sore, ulcer, cancer&#x27; (itself derived from karkinos meaning crab).^[4] As of 2004,..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/Carcinoma"/><meta property="og:title" content="Carcinoma"/><meta property="og:description" content="Carcinoma is a malignancy that develops from epithelial cells.^[1] Specifically, a carcinoma is a cancer that begins in a tissue that lines the inner or outer surfaces of the body, and that arises from cells originating in the endodermal, mesodermal or ectodermal germ layer during embryogenesis.^[5] Carcinomas represent 80-90% of all human cancers.^[48] It is from the Greek: καρκίνωμα, romanized: karkinōma, lit. &#x27;sore, ulcer, cancer&#x27; (itself derived from karkinos meaning crab).^[4] As of 2004,..."/><meta property="og:url" content="https://grokipedia.com/page/Carcinoma"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Carcinoma"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:13.317Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Carcinoma"/><meta name="twitter:description" content="Carcinoma is a malignancy that develops from epithelial cells.^[1] Specifically, a carcinoma is a cancer that begins in a tissue that lines the inner or outer surfaces of the body, and that arises from cells originating in the endodermal, mesodermal or ectodermal germ layer during embryogenesis.^[5] Carcinomas represent 80-90% of all human cancers.^[48] It is from the Greek: καρκίνωμα, romanized: karkinōma, lit. &#x27;sore, ulcer, cancer&#x27; (itself derived from karkinos meaning crab).^[4] As of 2004,..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="f6f005c0deec3d8b20aa6611f39f981b-ac57dc514f235228-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=f6f005c0deec3d8b20aa6611f39f981b,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.49345358340257617,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>⌘</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>⌘</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#carcinoma" class="transition-opacity hover:opacity-100 opacity-50">Carcinoma</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#carcinoma-classification" class="transition-opacity hover:opacity-100 opacity-50">Carcinoma Classification</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#classification" class="transition-opacity hover:opacity-100 opacity-50">Classification</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#histological-types" class="transition-opacity hover:opacity-100 opacity-50">Histological types</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#carcinoma-of-unknown-primary-site" class="transition-opacity hover:opacity-100 opacity-50">Carcinoma of unknown primary site</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#icd-o-morphology-codes" class="transition-opacity hover:opacity-100 opacity-50">ICD-O morphology codes</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#carcinoma-in-situ" class="transition-opacity hover:opacity-100 opacity-50">Carcinoma in situ</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pathogenesis" class="transition-opacity hover:opacity-100 opacity-50">Pathogenesis</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#metastatic-carcinoma" class="transition-opacity hover:opacity-100 opacity-50">Metastatic carcinoma</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#mutation" class="transition-opacity hover:opacity-100 opacity-50">Mutation</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#cause-of-mutations" class="transition-opacity hover:opacity-100 opacity-50">Cause of mutations</a></li><li style="padding-left:3rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#high-frequency" class="transition-opacity hover:opacity-100 opacity-50">High frequency</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#dna-repair" class="transition-opacity hover:opacity-100 opacity-50">DNA repair</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#diagnosis" class="transition-opacity hover:opacity-100 opacity-50">Diagnosis</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#staging" class="transition-opacity hover:opacity-100 opacity-50">Staging</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#grading" class="transition-opacity hover:opacity-100 opacity-50">Grading</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#epidemiology" class="transition-opacity hover:opacity-100 opacity-50">Epidemiology</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="carcinoma" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Carcinoma<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Carcinoma</strong> is a malignancy that develops from <em>epithelial cells</em>.^<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Specifically, a carcinoma is a <em>cancer</em> that begins in a tissue that lines the inner or outer surfaces of the body, and that arises from cells originating in the <em>endodermal</em>, <em>mesodermal</em> or <em>ectodermal germ layer</em> during <em>embryogenesis</em>.^<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Carcinomas represent 80-90% of all human cancers.^</span>
<span class="mb-4 block break-words text-[1em] leading-7">It is from the <em>Greek</em>: καρκίνωμα, <em>romanized</em>: <em>karkinōma</em>, <em>lit.</em> &#x27;sore, ulcer, cancer&#x27; (itself derived from <em>karkinos</em> meaning <em>crab</em>).^<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h1 id="carcinoma-classification" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Carcinoma Classification<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<h2 id="classification" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Classification<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">As of 2004, no simple and comprehensive classification system has been devised and accepted within the scientific community.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_23abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Subsequent developments include the World Health Organization&#x27;s (WHO) Classification of Tumours series (5th edition, ongoing since 2019), which offers detailed, site-specific classifications integrating histological and molecular criteria.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_43abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> Traditionally, however, malignancies have generally been classified into various types using a combination of criteria, including:<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_63abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The cell type from which they start; specifically:</span>
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">Epithelial cells ⇨ carcinoma</li>
<li class="text-[1em]">Non-hematopoietic mesenchymal cells ⇨ sarcoma</li>
<li class="text-[1em]">Hematopoietic cells
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">Bone marrow–derived cells that normally mature in the bloodstream ⇨ leukemia</li>
<li class="text-[1em]">Bone marrow-derived cells that normally mature in the lymphatic system ⇨ lymphoma</li>
</ul>
</li>
<li class="text-[1em]">Germ cells ⇨ germinoma</li>
</ul>
<span class="mb-4 block break-words text-[1em] leading-7">Other criteria that play a role include:</span>
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">The degree to which the malignant cells resemble their normal, untransformed counterparts</li>
<li class="text-[1em]">The appearance of the local tissue and stromal architecture</li>
<li class="text-[1em]">The anatomical location from which tumors arise</li>
<li class="text-[1em]">Genetic, epigenetic, and molecular features</li>
</ul>
<h3 id="histological-types" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Histological types<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Adenocarcinoma (adeno = gland)</strong><br/>
Refers to a carcinoma featuring microscopic glandular-related tissue cytology, tissue architecture, and/or gland-related molecular products, e.g., mucin.</span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Squamous cell carcinoma</strong><br/>
Refers to a carcinoma with observable features and characteristics indicative of squamous differentiation (intercellular bridges, keratinization, squamous pearls).</span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Adenosquamous carcinoma</strong><br/>
Refers to a mixed tumor containing both adenocarcinoma and squamous cell carcinoma, wherein each of these cell types comprise at least 10% of the tumor volume.</span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Anaplastic carcinoma</strong><br/>
Refers to a heterogeneous group of high-grade carcinomas that feature cells lacking distinct histological or cytological evidence of any of the more specifically differentiated neoplasms. These tumors are referred to as anaplastic or undifferentiated carcinomas.</span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Large cell carcinoma</strong><br/>
Composed of large, monotonous rounded or overtly polygonal-shaped cells with abundant cytoplasm.</span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Small cell carcinoma</strong><br/>
Cells are usually round and are less than approximately three times the diameter of a resting lymphocyte and with little evident cytoplasm. Occasionally, small cell malignancies may themselves have significant components of slightly polygonal and/or spindle-shaped cells.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_48qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">There are a large number of rare subtypes of anaplastic, undifferentiated carcinoma. Some of the more well known include the lesions containing pseudo-sarcomatous components: spindle cell carcinoma (containing elongated cells resembling connective tissue cancers), giant cell carcinoma (containing huge, bizarre, multinucleated cells), and sarcomatoid carcinoma (mixtures of spindle and giant cell carcinoma). Pleomorphic carcinoma contains spindle cell and/or giant cell components, plus at least a 10% component of cells characteristic of more highly differentiated types (i.e. adenocarcinoma and/or squamous cell carcinoma). Very rarely, tumors may contain individual components resembling both carcinoma and true sarcoma, including carcinosarcoma and pulmonary blastoma.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_29abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> A history of cigarette smoking is the most common cause of large cell carcinoma.</span>
<h3 id="carcinoma-of-unknown-primary-site" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Carcinoma of unknown primary site<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Immunohistochemistry for cytokeratin 7 and cytokeratin 20 can give a clue about possible origins of carcinomas of unknown primary site.</span>
<span class="mb-4 block break-words text-[1em] leading-7">The term carcinoma has also come to encompass malignant tumors composed of transformed cells whose origin or developmental lineage is unknown (see cancer of unknown primary origin; CUP), but that possess certain specific molecular, cellular, and histological characteristics typical of epithelial cells. This may include the production of one or more forms of cytokeratin or other intermediate filaments, intercellular bridge structures, keratin pearls, and/or tissue architectural motifs such as stratification or pseudo-stratification.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup></span>
<h3 id="icd-o-morphology-codes" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">ICD-O morphology codes<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">These are morphology codes from ICD-O-3.2.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup></span>
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">(8010-8045) Epithelial neoplasms, NOS</li>
<li class="text-[1em]">(8050-8080) Squamous cell neoplasms
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">(M8070/3) Squamous cell carcinoma, NOS</li>
</ul>
</li>
<li class="text-[1em]">(8090-8110) Basal cell neoplasms
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">(M8090/3) Basal cell carcinoma, NOS</li>
</ul>
</li>
<li class="text-[1em]">(8120-8130) Transitional cell carcinomas</li>
<li class="text-[1em]">(8140-8380) Adenocarcinomas
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">(M8140/3) Adenocarcinoma, NOS</li>
<li class="text-[1em]">(M8142/3) Linitis plastica</li>
<li class="text-[1em]">(M8155/3) Vipoma</li>
<li class="text-[1em]">(M8160/3) Cholangiocarcinoma</li>
<li class="text-[1em]">(M8170/3) Hepatocellular carcinoma, NOS</li>
<li class="text-[1em]">(M8200/3) Adenoid cystic carcinoma</li>
<li class="text-[1em]">(M8312/3) Renal cell carcinoma</li>
<li class="text-[1em]">(M8312/3) Grawitz tumor</li>
</ul>
</li>
<li class="text-[1em]">(8390-8420) Adnexal and Skin appendage Neoplasms</li>
<li class="text-[1em]">(8430-8439) Mucoepidermoid Neoplasms</li>
<li class="text-[1em]">(8440-8490) Cystic, Mucinous and Serous Neoplasms</li>
<li class="text-[1em]">(8500-8540) Ductal, Lobular and Medullary Neoplasms</li>
<li class="text-[1em]">(8550-8559) Acinar cell neoplasms</li>
<li class="text-[1em]">(8560-8580) Complex epithelial neoplasms</li>
</ul>
<h3 id="carcinoma-in-situ" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Carcinoma <em>in situ</em><button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The term carcinoma in situ (or CIS) is a term for cells that are significantly abnormal but not cancer.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup> They are thus not typically carcinomas.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup></span>
<h1 id="pathogenesis" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Pathogenesis<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">Cancer occurs when a single progenitor cell accumulates <span class="inline text-[1em] leading-7">mutations</span> and other changes in the <span class="inline text-[1em] leading-7">DNA</span>, <span class="inline text-[1em] leading-7">histones</span>, and other biochemical compounds that make up the cell&#x27;s <span class="inline text-[1em] leading-7">genome</span>. The cell genome controls the structure of the cell&#x27;s biochemical components, the biochemical reactions that occur within the cell, and the biological interactions of that cell with other cells. Certain combinations of mutations in the given progenitor cell ultimately result in that cell (also called a cancer stem cell) displaying a number of abnormal, <span class="inline text-[1em] leading-7">malignant</span> cellular properties that, when taken together, are considered characteristic of cancer, including:</span>
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">the ability to continue to divide perpetually, producing an exponentially (or near-exponentially) increasing number of new malignant cancerous &quot;daughter cells&quot; (uncontrolled <span class="inline text-[1em] leading-7">mitosis</span>);</li>
<li class="text-[1em]">the ability to penetrate normal body surfaces and barriers, and to bore into or through nearby body structures and tissues (local invasiveness);</li>
<li class="text-[1em]">the ability to spread to other sites within the body (<span class="inline text-[1em] leading-7">metastasize</span>) by penetrating or entering into the <span class="inline text-[1em] leading-7">lymphatic vessels</span> (regional metastasis) and/or the <span class="inline text-[1em] leading-7">blood vessels</span> (distant metastasis).</li>
</ul>
<span class="mb-4 block break-words text-[1em] leading-7">If this process of continuous growth, local invasion, and regional and distant metastasis is not halted via a combination of stimulation of immunological defenses and medical treatment interventions, the result is that the host has a continuously increasing burden of tumor cells throughout the body. Eventually, the tumor burden increasingly interferes with normal biochemical functions carried out by the host&#x27;s <span class="inline text-[1em] leading-7">organs</span>, and <span class="inline text-[1em] leading-7">death</span> ultimately ensues.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Carcinoma is but one form of cancer—one composed of cells that have developed the cytological appearance, histological architecture, or molecular characteristics of epithelial cells.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> A progenitor carcinoma stem cell can be formed from any of a number of oncogenic combinations of mutations in a multipotent cell,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup> or a mature <span class="inline text-[1em] leading-7">differentiated</span> cell.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup></span>
<h3 id="metastatic-carcinoma" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Metastatic carcinoma<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Metastatic carcinoma is cancer that has spread from where it started (the primary site) to a distant part of the body. The process occurs when cancer cells break away from the primary tumor and travel through the lymphatic system or bloodstream to form new (secondary) tumors at other sites.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup></span>
<h3 id="mutation" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Mutation<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Whole genome sequencing</span> has established the mutation frequency for whole human genomes. The mutation frequency in the whole genome between generations for humans (parent to child) is about 70 new mutations per generation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Carcinomas, however, have much higher mutation frequencies. The particular frequency depends on tissue type, whether a mis-match DNA repair deficiency is present, and exposure to DNA damaging agents such as components of tobacco smoke. Tuna and Amos have summarized the mutation frequencies per megabase (Mb) in some carcinomas,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup> as shown in the table (along with the indicated frequencies of mutations per genome).</span>











































































<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Cell type</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Per megabase</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Per diploid genome</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Germline</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.023</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">70</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Prostate cancer</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.9</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">5,400</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Colorectal carcinoma</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~5</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~30,000</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Microsatellite stable (MSS) colon cancer</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2.8</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">16,800</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Microsatellite instable (MSI) colon cancer (mismatch repair deficient)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">47</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">282,000</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Hepatocellular carcinoma</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">4.2</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">25,200</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Breast cancer</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">1.18–1.66</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">7,080–9,960</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Lung cancer</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">17.7</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">106,200</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Small cell lung cancer</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">7.4</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">44,400</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Non-small cell lung cancer (smokers)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">10.5</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">63,000</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Non-small cell lung cancer (never-smokers)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.6</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">3,600</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Lung adenocarcinoma (smokers)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">9.8</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">58,500</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Lung adenocarcinoma (never-smokers)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">1.7</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">10,200</span></td></tr></tbody></table></div>
<h4 id="cause-of-mutations" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Cause of mutations<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">The likely major underlying cause of mutations in carcinomas is DNA damage. For example, in the case of lung cancer, DNA damage is caused by agents in <span class="inline text-[1em] leading-7">exogenous</span> <span class="inline text-[1em] leading-7">genotoxic</span> tobacco smoke (e.g. <span class="inline text-[1em] leading-7">acrolein</span>, <span class="inline text-[1em] leading-7">formaldehyde</span>, <span class="inline text-[1em] leading-7">acrylonitrile</span>, <span class="inline text-[1em] leading-7">1,3-butadiene</span>, <span class="inline text-[1em] leading-7">acetaldehyde</span>, <span class="inline text-[1em] leading-7">ethylene oxide</span> and <span class="inline text-[1em] leading-7">isoprene</span>).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kjqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup> <span class="inline text-[1em] leading-7">Endogenous (metabolically caused) DNA damage</span> is also very frequent, occurring on average more than 60,000 times a day in the genomes of human cells. Externally and endogenously caused damages may be converted into mutations by inaccurate <span class="inline text-[1em] leading-7">translesion synthesis</span> or inaccurate DNA repair (e.g. by <span class="inline text-[1em] leading-7">non-homologous end joining</span>).</span>
<h5 id="high-frequency" class="group relative mb-1 mt-4 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">High frequency<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h5>
<span class="mb-4 block break-words text-[1em] leading-7">The high frequency of mutations in the total genome within carcinomas suggests that, often, an early carcinogenic alteration may be a deficiency in DNA repair. For instance, mutation rates substantially increase (sometimes by 100-fold) in cells defective in <span class="inline text-[1em] leading-7">DNA mismatch repair</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A deficiency in DNA repair, itself, can allow DNA damages to accumulate, and error-prone <span class="inline text-[1em] leading-7">translesion synthesis</span> past some of those damages may give rise to mutations. In addition, faulty repair of these accumulated DNA damages may give rise to <span class="inline text-[1em] leading-7">epigenetic alterations or epimutations</span>. While a mutation or epimutation in a DNA repair gene, itself, would not confer a selective advantage, such a repair defect may be carried along as a passenger in a cell when the cell acquires an additional mutation/epimutation that does provide a proliferative advantage. Such cells, with both proliferative advantages and one or more DNA repair defects (causing a very high mutation rate), likely give rise to the high frequency of total genome mutations seen in carcinomas.</span>
<h4 id="dna-repair" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">DNA repair<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">In somatic cells, deficiencies in DNA repair sometimes arise by mutations in DNA repair genes, but much more often are due to <span class="inline text-[1em] leading-7">epigenetic</span> reductions in expression of DNA repair genes. Thus, in a sequence of 113 colorectal carcinomas, only four had somatic missense mutations in the DNA repair gene <em><span class="inline text-[1em] leading-7">MGMT</span></em> , while the majority of these cancers had reduced MGMT protein expression due to methylation of the <em>MGMT</em> promoter region.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8mabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup></span>
<h2 id="diagnosis" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Diagnosis<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Diagnosis of carcinoma typically begins with clinical evaluation, including history, physical examination, laboratory tests (such as complete blood count and tumor markers), and imaging studies (e.g., CT, MRI, PET scans) to identify suspicious lesions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup> Carcinomas can be definitively diagnosed through <span class="inline text-[1em] leading-7">biopsy</span>, including <span class="inline text-[1em] leading-7">fine-needle aspiration</span> (FNA), <span class="inline text-[1em] leading-7">core biopsy</span>, or subtotal removal of a single node. Microscopic examination by a <span class="inline text-[1em] leading-7">pathologist</span> is then necessary to identify molecular, cellular, or tissue architectural characteristics of epithelial cells.</span>
<h3 id="staging" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Staging<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Staging</span> of carcinoma refers to the process of combining physical/clinical examination, pathological review of cells and tissues, surgical techniques, laboratory tests, and imaging studies in a logical fashion to obtain information about the size of the neoplasm and the extent of its invasion and <span class="inline text-[1em] leading-7">metastasis</span>. Carcinoma stage is the variable that has been most consistently and tightly linked to the <span class="inline text-[1em] leading-7">prognosis</span> of the malignancy.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Carcinomas are usually staged with Roman numerals. In most classifications, Stage I and Stage II carcinomas are confirmed when the tumor has been found to be small and/or to have spread to local structures only. Stage III carcinomas typically have been found to have spread to regional lymph nodes, tissues, and/or organ structures, while Stage IV tumors have already metastasized through the <span class="inline text-[1em] leading-7">blood</span> to distant sites, tissues, or organs.</span>
<span class="mb-4 block break-words text-[1em] leading-7">In some types of carcinomas, Stage 0 carcinoma has been used to describe <span class="inline text-[1em] leading-7">carcinoma <em>in situ</em></span>, and <span class="inline text-[1em] leading-7">occult</span> carcinomas detectable only via examination of <span class="inline text-[1em] leading-7">sputum</span> for malignant cells (in <span class="inline text-[1em] leading-7">lung carcinomas</span>).</span>
<span class="mb-4 block break-words text-[1em] leading-7">In more recent staging systems, substages (a, b, c) are becoming more commonly used to better define groups of patients with similar prognosis or treatment options.</span>
<span class="mb-4 block break-words text-[1em] leading-7">The criteria for staging can differ dramatically based upon the organ system in which the tumor arises. For example, the colon<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> and bladder cancer<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup> staging system relies on depth of invasion, staging of breast carcinoma is more dependent on the size of the tumor, and in renal carcinoma, staging is based on both the size of the tumor and the depth of the tumor invasion into the renal sinus. Carcinoma of the lung has a more complicated staging system, taking into account a number of size and anatomic variables.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The UICC/AJCC <span class="inline text-[1em] leading-7">TNM</span> systems are most often used.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup> For some common tumors, however, classical staging methods (such as the <span class="inline text-[1em] leading-7">Dukes classification</span> for <span class="inline text-[1em] leading-7">colon cancer</span>) are still used.</span>
<h3 id="grading" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Grading<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Grading of carcinomas refers to the employment of criteria intended to semi-quantify the degree of cellular and tissue maturity seen in the transformed cells relative to the appearance of the normal parent epithelial tissue from which the carcinoma derives.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Grading of carcinoma is most often done after a treating physician and/or surgeon obtains a sample of suspected tumor tissue using <span class="inline text-[1em] leading-7">surgical resection</span>, needle or surgical <span class="inline text-[1em] leading-7">biopsy</span>, direct washing or brushing of tumor tissue, <span class="inline text-[1em] leading-7">sputum</span> <span class="inline text-[1em] leading-7">cytopathology</span>, etc. A <span class="inline text-[1em] leading-7">pathologist</span> then examines the tumor and its <span class="inline text-[1em] leading-7">stroma</span>, perhaps utilizing <span class="inline text-[1em] leading-7">staining</span>, <span class="inline text-[1em] leading-7">immunohistochemistry</span>, <span class="inline text-[1em] leading-7">flow cytometry</span>, or other methods. Finally, the pathologist classifies the tumor semi-quantitatively into one of three or four grades, including:</span>
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">Grade 1, or well differentiated: there is a close, or very close, resemblance to the normal parent tissue, and the tumor cells are easily identified and classified as a particular malignant histological entity;</li>
<li class="text-[1em]">Grade 2, or moderately differentiated: there is considerable resemblance to the parent cells and tissues, but abnormalities can commonly be seen and the more complex features are not particularly well-formed;</li>
<li class="text-[1em]">Grade 3, or poorly differentiated: there is very little resemblance between the malignant tissue and the normal parent tissue, abnormalities are evident, and the more complex architectural features are usually rudimentary or primitive;</li>
<li class="text-[1em]">Grade 4, or undifferentiated carcinoma: these carcinomas bear no significant resemblance to the corresponding parent cells and tissues, with no visible formation of glands, ducts, bridges, stratified layers, keratin pearls, or other notable characteristics consistent with a more highly differentiated neoplasm.</li>
</ul>
<span class="mb-4 block break-words text-[1em] leading-7">Although there is definite and convincing statistical <span class="inline text-[1em] leading-7">correlation</span> between carcinoma grade and tumor prognosis for some tumor types and sites of origin, the strength of this association can be highly variable. It may be stated generally, however, that the higher the grade of the lesion, the worse is its prognosis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup></span>
<h2 id="epidemiology" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Epidemiology<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Carcinomas account for approximately 80-90% of all human cancers, making them the most common type of malignancy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2uabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> In 2020, there were an estimated 10 million new cases of carcinoma worldwide, with the majority occurring in adults over 50 years of age. <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4uabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> In the United States, about 1.7 million of the 1.9 million annual cancer diagnoses as of 2025 are carcinomas. <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6uabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup> Incidence rates vary by type and region, with higher rates in developed countries due to aging populations and lifestyle factors.</span>
<span class="mb-4 block break-words text-[1em] leading-7">While cancer is generally considered a disease of old age, children can also develop cancer. In contrast to adults, carcinomas are exceptionally rare in children, comprising about 5% of pediatric cancers and less than 0.1% of all carcinoma diagnoses. <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2uqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup> Approximately 9,550 children under age 20 in the US are diagnosed with cancer annually as of 2025, with only a few hundred being carcinomas. <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4uqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Major risk factors for carcinomas include advanced age, tobacco use, obesity, and environmental exposures, though these vary by subtype. For ovarian carcinoma specifically, age (most common over 55) and family history (including BRCA mutations) are among the primary risk factors. <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2vabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup></span></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="1" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kirkham N, Lemoine NR (2001). <a href="https://books.google.com/books?id=xiHcyr-BHeQC&amp;pg=PT61" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Progress in pathology</em></a>. London: Greenwich Medical Media. p. 52. <span class="inline text-[1em] leading-7">ISBN</span> 9781841100500.</span></div></li><li id="5" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Berman JJ (March 2004). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC415552" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Tumor classification: molecular analysis meets Aristotle&quot;</a>. <em>BMC Cancer</em>. <strong>4</strong> (1): 10. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1186%2F1471-2407-4-10" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1186/1471-2407-4-10</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC415552" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">415552</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15113444" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15113444</a>.</span></div></li><li id="4" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><em><span class="inline text-[1em] leading-7">Oxford English Dictionary</span>, 3rd edition, </em><a href="http://www.oed.com/view/Entry/27823" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">s.v.__</a></span></div></li><li id="https://tumourclassification.iarc.who.int/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://tumourclassification.iarc.who.int/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://tumourclassification.iarc.who.int/</a></span></div></li><li id="6" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Berman JJ (November 2004). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535937" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Tumor taxonomy for the developmental lineage classification of neoplasms&quot;</a>. <em>BMC Cancer</em>. <strong>4</strong> (1): 88. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1186%2F1471-2407-4-88" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1186/1471-2407-4-88</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535937" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">535937</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15571625" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15571625</a>.</span></div></li><li id="8" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, eds. (2004). <a href="https://web.archive.org/web/20090823210304/http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-cover.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart</em></a> (PDF). World Health Organization Classification of Tumours. Lyon: IARC Press. <span class="inline text-[1em] leading-7">ISBN</span> 978-92-832-2418-1. Archived from <a href="http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-cover.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> (PDF) on 23 August 2009. Retrieved 27 January 2014.</span></div></li><li id="https://seer.cancer.gov/icd-o-3/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://seer.cancer.gov/icd-o-3/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://seer.cancer.gov/icd-o-3/</a></span></div></li><li id="10" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Chang A (2007). <a href="https://books.google.com/books?id=vxh6u1-ETk0C&amp;pg=PA162" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Oncology: An Evidence-Based Approach</em></a>. Springer. p. 162. <span class="inline text-[1em] leading-7">ISBN</span> 9780387310565.</span></div></li><li id="11" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Looijenga LH, Hersmus R, de Leeuw BH, Stoop H, Cools M, Oosterhuis JW, et al. (April 2010). &quot;Gonadal tumours and DSD&quot;. <em>Best Practice &amp; Research. Clinical Endocrinology &amp; Metabolism</em>. <strong>24</strong> (2): 291–310. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.beem.2009.10.002" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.beem.2009.10.002</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20541153" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20541153</a>.</span></div></li><li id="12" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">&quot;Carcinoma&quot;. Academic Press Dictionary of Science and Technology. <code class="text-fg-solar bg-fg-solar-opaque break-all rounded px-2 align-middle font-mono text-sm" node="[object Object]">{{cite journal}}</code>: Cite journal requires <code class="text-fg-solar bg-fg-solar-opaque break-all rounded px-2 align-middle font-mono text-sm" node="[object Object]">|journal=</code> (help)</span></div></li><li id="13" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Vassilev A, DePamphilis ML (January 2017). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333035" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Links between DNA Replication, Stem Cells and Cancer&quot;</a>. <em>Genes</em>. <strong>8</strong> (2): 45. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3390%2Fgenes8020045" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3390/genes8020045</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333035" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5333035</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/28125050" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">28125050</a>.</span></div></li><li id="14" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Anandakrishnan R, Varghese RT, Kinney NA, Garner HR (March 2019). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424461" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Estimating the number of genetic mutations (hits) required for carcinogenesis based on the distribution of somatic mutations&quot;</a>. <em>PLOS Computational Biology</em>. <strong>15</strong> (3): e1006881. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2019PLSCB..15E6881A" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2019PLSCB..15E6881A</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1371%2Fjournal.pcbi.1006881" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1371/journal.pcbi.1006881</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424461" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6424461</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/30845172" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">30845172</a>.</span></div></li><li id="https://www.cancer.gov/types/metastatic-cancer" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cancer.gov/types/metastatic-cancer" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cancer.gov/types/metastatic-cancer</a></span></div></li><li id="16" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Roach JC, Glusman G, Smit AF, Huff CD, Hubley R, Shannon PT, et al. (April 2010). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037280" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Analysis of genetic inheritance in a family quartet by whole-genome sequencing&quot;</a>. <em>Science</em>. <strong>328</strong> (5978): 636–639. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2010Sci...328..636R" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2010Sci...328..636R</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1126%2Fscience.1186802" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1126/science.1186802</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037280" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3037280</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20220176" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20220176</a>.</span></div></li><li id="17" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Tuna M, Amos CI (November 2013). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622788" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Genomic sequencing in cancer&quot;</a>. <em>Cancer Letters</em>. <strong>340</strong> (2): 161–170. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.canlet.2012.11.004" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.canlet.2012.11.004</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622788" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3622788</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23178448" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23178448</a>.</span></div></li><li id="18" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Cunningham FH, Fiebelkorn S, Johnson M, Meredith C (November 2011). &quot;A novel application of the Margin of Exposure approach: segregation of tobacco smoke toxicants&quot;. <em>Food and Chemical Toxicology</em>. <strong>49</strong> (11): 2921–2933. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.fct.2011.07.019" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.fct.2011.07.019</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21802474" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21802474</a>.</span></div></li><li id="19" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Hegan DC, Narayanan L, Jirik FR, Edelmann W, Liskay RM, Glazer PM (December 2006). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612936" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6&quot;</a>. <em>Carcinogenesis</em>. <strong>27</strong> (12): 2402–2408. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1093%2Fcarcin%2Fbgl079" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1093/carcin/bgl079</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612936" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2612936</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16728433" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16728433</a>.</span></div></li><li id="20" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Halford S, Rowan A, Sawyer E, Talbot I, Tomlinson I (June 2005). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774551" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;O(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C&gt;A:T transitions&quot;</a>. <em>Gut</em>. <strong>54</strong> (6): 797–802. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1136%2Fgut.2004.059535" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1136/gut.2004.059535</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774551" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1774551</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15888787" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15888787</a>.</span></div></li><li id="21" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Wagman LD (2008). <a href="https://web.archive.org/web/20131004224102/http://www.cancernetwork.com/cancer-management-11/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Principles of Surgical Oncology&quot;</a>. In Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (eds.). <a href="http://www.cancernetwork.com/cancer-management-11/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Cancer Management: A Multidisciplinary Approach</em></a> (11th ed.). Archived from <a href="http://www.cancernetwork.com/cancer-management-11/chapter01/article/10165/1399286" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 4 October 2013. Retrieved 8 June 2009.</span></div></li><li id="23" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Puppa G, Sonzogni A, Colombari R, Pelosi G (June 2010). &quot;TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues&quot;. <em>Archives of Pathology &amp; Laboratory Medicine</em>. <strong>134</strong> (6): 837–852. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.5858%2F134.6.837" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.5858/134.6.837</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20524862" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20524862</a>.</span></div></li><li id="24" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Sharir S (February 2006). &quot;Update on clinical and radiological staging and surveillance of bladder cancer&quot;. <em>The Canadian Journal of Urology</em>. <strong>13</strong> (Suppl 1): 71–76. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16526987" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16526987</a>.</span></div></li><li id="25" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Pepek JM, Chino JP, Marks LB, D&#x27;amico TA, Yoo DS, Onaitis MW, et al. (April 2011). <a href="https://doi.org/10.1097%2FJTO.0b013e31821038c0" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: A comparison of the TNM 6 and 7 systems&quot;</a>. <em>Journal of Thoracic Oncology</em>. <strong>6</strong> (4): 757–761. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1097%2FJTO.0b013e31821038c0" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1097/JTO.0b013e31821038c0</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21325975" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21325975</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:24598745" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">24598745</a>.</span></div></li><li id="26" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://web.archive.org/web/20071025013538/http://cancerstaging.org/mission/whatis.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;What is Cancer Staging?&quot;</a>. Archived from <a href="http://www.cancerstaging.org/mission/whatis.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 25 October 2007. Retrieved 27 January 2014.</span></div></li><li id="27" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Sun Z, Aubry MC, Deschamps C, Marks RS, Okuno SH, Williams BA, et al. (May 2006). <a href="https://doi.org/10.1016%2Fj.jtcvs.2005.12.057" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases&quot;</a>. <em>The Journal of Thoracic and Cardiovascular Surgery</em>. <strong>131</strong> (5): 1014–1020. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.jtcvs.2005.12.057" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.jtcvs.2005.12.057</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16678584" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16678584</a>.</span></div></li><li id="28" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.uptodate.com/contents/poorly-differentiated-cancer-from-an-unknown-primary-site" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Poorly differentiated cancer from an unknown primary site&quot;</a>. Retrieved 6 June 2022.</span></div></li><li id="https://gco.iarc.who.int/media/globocan/factsheets/cancers/30-31-39-multiple-myeloma-globocan-2022.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://gco.iarc.who.int/media/globocan/factsheets/cancers/30-31-39-multiple-myeloma-globocan-2022.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://gco.iarc.who.int/media/globocan/factsheets/cancers/30-31-39-multiple-myeloma-globocan-2022.pdf</a></span></div></li><li id="https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2025-cancer-facts-figures.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2025-cancer-facts-figures.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2025-cancer-facts-figures.html</a></span></div></li><li id="https://www.cancer.gov/types/childhood-cancers/child-adolescent-cancers-fact-sheet" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cancer.gov/types/childhood-cancers/child-adolescent-cancers-fact-sheet" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cancer.gov/types/childhood-cancers/child-adolescent-cancers-fact-sheet</a></span></div></li><li id="https://www.cancer.org/cancer/types/ovarian-cancer/causes-risks-prevention/risk-factors.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cancer.org/cancer/types/ovarian-cancer/causes-risks-prevention/risk-factors.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cancer.org/cancer/types/ovarian-cancer/causes-risks-prevention/risk-factors.html</a></span></div></li></ol></div><div class="text-fg-secondary text-xs [&amp;_*]:mb-2"><hr class="border-border-l1 my-8 rounded-sm border-t"/>
<span class="mb-4 block break-words text-[1em] leading-7">The content is adapted from <a href="https://en.wikipedia.org/wiki/Carcinoma" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Wikipedia</a>, licensed under Creative Commons Attribution-ShareAlike 4.0 License.</span></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1" id="_R_" async=""></script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\"}]\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"Carcinoma\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"Carcinoma\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"Carcinoma\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"21:I[6367,[],\"IconMark\"]\n1f:T504c,"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"# Carcinoma\n\n**Carcinoma** is a malignancy that develops from _epithelial cells_.^[1] Specifically, a carcinoma is a _cancer_ that begins in a tissue that lines the inner or outer surfaces of the body, and that arises from cells originating in the _endodermal_, _mesodermal_ or _ectodermal germ layer_ during _embryogenesis_.^[5]\n\nCarcinomas represent 80-90% of all human cancers.^[48]\n\nIt is from the _Greek_: καρκίνωμα, _romanized_: _karkinōma_, _lit._ 'sore, ulcer, cancer' (itself derived from _karkinos_ meaning _crab_).^[4]\n# Carcinoma Classification\n\n## Classification\n\nAs of 2004, no simple and comprehensive classification system has been devised and accepted within the scientific community.[5] Subsequent developments include the World Health Organization's (WHO) Classification of Tumours series (5th edition, ongoing since 2019), which offers detailed, site-specific classifications integrating histological and molecular criteria.[](https://tumourclassification.iarc.who.int/) Traditionally, however, malignancies have generally been classified into various types using a combination of criteria, including:[6]\n\nThe cell type from which they start; specifically: \n\n* Epithelial cells ⇨ carcinoma\n* Non-hematopoietic mesenchymal cells ⇨ sarcoma\n* Hematopoietic cells \n  * Bone marrow–derived cells that normally mature in the bloodstream ⇨ leukemia\n  * Bone marrow-derived cells that normally mature in the lymphatic system ⇨ lymphoma\n* Germ cells ⇨ germinoma\n\nOther criteria that play a role include: \n\n* The degree to which the malignant cells resemble their normal, untransformed counterparts\n* The appearance of the local tissue and stromal architecture\n* The anatomical location from which tumors arise\n* Genetic, epigenetic, and molecular features\n\n### Histological types\n\n**Adenocarcinoma (adeno = gland)**  \nRefers to a carcinoma featuring microscopic glandular-related tissue cytology, tissue architecture, and/or gland-related molecular products, e.g., mucin.\n\n**Squamous cell carcinoma**  \nRefers to a carcinoma with observable features and characteristics indicative of squamous differentiation (intercellular bridges, keratinization, squamous pearls).\n\n**Adenosquamous carcinoma**  \nRefers to a mixed tumor containing both adenocarcinoma and squamous cell carcinoma, wherein each of these cell types comprise at least 10% of the tumor volume.\n\n**Anaplastic carcinoma**  \nRefers to a heterogeneous group of high-grade carcinomas that feature cells lacking distinct histological or cytological evidence of any of the more specifically differentiated neoplasms. These tumors are referred to as anaplastic or undifferentiated carcinomas.\n\n**Large cell carcinoma**  \nComposed of large, monotonous rounded or overtly polygonal-shaped cells with abundant cytoplasm.\n\n**Small cell carcinoma**  \nCells are usually round and are less than approximately three times the diameter of a resting lymphocyte and with little evident cytoplasm. Occasionally, small cell malignancies may themselves have significant components of slightly polygonal and/or spindle-shaped cells.[8]\n\nThere are a large number of rare subtypes of anaplastic, undifferentiated carcinoma. Some of the more well known include the lesions containing pseudo-sarcomatous components: spindle cell carcinoma (containing elongated cells resembling connective tissue cancers), giant cell carcinoma (containing huge, bizarre, multinucleated cells), and sarcomatoid carcinoma (mixtures of spindle and giant cell carcinoma). Pleomorphic carcinoma contains spindle cell and/or giant cell components, plus at least a 10% component of cells characteristic of more highly differentiated types (i.e. adenocarcinoma and/or squamous cell carcinoma). Very rarely, tumors may contain individual components resembling both carcinoma and true sarcoma, including carcinosarcoma and pulmonary blastoma.[8] A history of cigarette smoking is the most common cause of large cell carcinoma. \n\n### Carcinoma of unknown primary site\n\nImmunohistochemistry for cytokeratin 7 and cytokeratin 20 can give a clue about possible origins of carcinomas of unknown primary site.[9]\n\nThe term carcinoma has also come to encompass malignant tumors composed of transformed cells whose origin or developmental lineage is unknown (see cancer of unknown primary origin; CUP), but that possess certain specific molecular, cellular, and histological characteristics typical of epithelial cells. This may include the production of one or more forms of cytokeratin or other intermediate filaments, intercellular bridge structures, keratin pearls, and/or tissue architectural motifs such as stratification or pseudo-stratification.[5][6]\n\n### ICD-O morphology codes\n\nThese are morphology codes from ICD-O-3.2.[](https://seer.cancer.gov/icd-o-3/)\n* (8010-8045) Epithelial neoplasms, NOS\n* (8050-8080) Squamous cell neoplasms\n  * (M8070/3) Squamous cell carcinoma, NOS\n* (8090-8110) Basal cell neoplasms\n  * (M8090/3) Basal cell carcinoma, NOS\n* (8120-8130) Transitional cell carcinomas\n* (8140-8380) Adenocarcinomas\n  * (M8140/3) Adenocarcinoma, NOS\n  * (M8142/3) Linitis plastica\n  * (M8155/3) Vipoma\n  * (M8160/3) Cholangiocarcinoma\n  * (M8170/3) Hepatocellular carcinoma, NOS\n  * (M8200/3) Adenoid cystic carcinoma\n  * (M8312/3) Renal cell carcinoma\n  * (M8312/3) Grawitz tumor\n* (8390-8420) Adnexal and Skin appendage Neoplasms\n* (8430-8439) Mucoepidermoid Neoplasms\n* (8440-8490) Cystic, Mucinous and Serous Neoplasms\n* (8500-8540) Ductal, Lobular and Medullary Neoplasms\n* (8550-8559) Acinar cell neoplasms\n* (8560-8580) Complex epithelial neoplasms\n\n### Carcinoma _in situ_\n\nThe term carcinoma in situ (or CIS) is a term for cells that are significantly abnormal but not cancer.[10] They are thus not typically carcinomas.[11]\n# Pathogenesis\n\nCancer occurs when a single progenitor cell accumulates [mutations](Mutations \"Mutations\") and other changes in the [DNA](DNA \"DNA\"), [histones](Histones \"Histones\"), and other biochemical compounds that make up the cell's [genome](Genome \"Genome\"). The cell genome controls the structure of the cell's biochemical components, the biochemical reactions that occur within the cell, and the biological interactions of that cell with other cells. Certain combinations of mutations in the given progenitor cell ultimately result in that cell (also called a cancer stem cell) displaying a number of abnormal, [malignant](Malignant \"Malignant\") cellular properties that, when taken together, are considered characteristic of cancer, including: \n\n* the ability to continue to divide perpetually, producing an exponentially (or near-exponentially) increasing number of new malignant cancerous \"daughter cells\" (uncontrolled [mitosis](Mitosis \"Mitosis\"));\n* the ability to penetrate normal body surfaces and barriers, and to bore into or through nearby body structures and tissues (local invasiveness);\n* the ability to spread to other sites within the body ([metastasize](Metastasis \"Metastasis\")) by penetrating or entering into the [lymphatic vessels](Lymphatic_vessels \"Lymphatic vessels\") (regional metastasis) and/or the [blood vessels](Blood_vessels \"Blood vessels\") (distant metastasis).[12]\n\nIf this process of continuous growth, local invasion, and regional and distant metastasis is not halted via a combination of stimulation of immunological defenses and medical treatment interventions, the result is that the host has a continuously increasing burden of tumor cells throughout the body. Eventually, the tumor burden increasingly interferes with normal biochemical functions carried out by the host's [organs](Organ_\\(anatomy\\) \"Organ \\(anatomy\\)\"), and [death](Death \"Death\") ultimately ensues. \n\nCarcinoma is but one form of cancer—one composed of cells that have developed the cytological appearance, histological architecture, or molecular characteristics of epithelial cells.[5][6] A progenitor carcinoma stem cell can be formed from any of a number of oncogenic combinations of mutations in a multipotent cell,[13] or a mature [differentiated](Cellular_differentiation \"Cellular differentiation\") cell.[14]\n\n### Metastatic carcinoma\n\nMetastatic carcinoma is cancer that has spread from where it started (the primary site) to a distant part of the body. The process occurs when cancer cells break away from the primary tumor and travel through the lymphatic system or bloodstream to form new (secondary) tumors at other sites.[](https://www.cancer.gov/types/metastatic-cancer)\n\n### Mutation\n\n[Whole genome sequencing](Whole_genome_sequencing \"Whole genome sequencing\") has established the mutation frequency for whole human genomes. The mutation frequency in the whole genome between generations for humans (parent to child) is about 70 new mutations per generation.[16]\n\nCarcinomas, however, have much higher mutation frequencies. The particular frequency depends on tissue type, whether a mis-match DNA repair deficiency is present, and exposure to DNA damaging agents such as components of tobacco smoke. Tuna and Amos have summarized the mutation frequencies per megabase (Mb) in some carcinomas,[17] as shown in the table (along with the indicated frequencies of mutations per genome). \n\n| Cell type                                      | Per megabase | Per diploid genome |\n|------------------------------------------------|--------------|--------------------|\n| Germline                                       | 0.023        | 70                 |\n| Prostate cancer                                | 0.9          | 5,400              |\n| Colorectal carcinoma                           | ~5           | ~30,000            |\n| Microsatellite stable (MSS) colon cancer       | 2.8          | 16,800             |\n| Microsatellite instable (MSI) colon cancer (mismatch repair deficient) | 47 | 282,000 |\n| Hepatocellular carcinoma                       | 4.2          | 25,200             |\n| Breast cancer                                  | 1.18–1.66    | 7,080–9,960        |\n| Lung cancer                                    | 17.7         | 106,200            |\n| Small cell lung cancer                         | 7.4          | 44,400             |\n| Non-small cell lung cancer (smokers)           | 10.5         | 63,000             |\n| Non-small cell lung cancer (never-smokers)     | 0.6          | 3,600              |\n| Lung adenocarcinoma (smokers)                  | 9.8          | 58,500             |\n| Lung adenocarcinoma (never-smokers)            | 1.7          | 10,200             |\n\n#### Cause of mutations\n\nFurther information: [DNA damage (naturally occurring)](DNA_damage_\\(naturally_occurring\\) \"DNA damage \\(naturally occurring\\)\")\n\nThe likely major underlying cause of mutations in carcinomas is DNA damage. For example, in the case of lung cancer, DNA damage is caused by agents in [exogenous](Exogeny \"Exogeny\") [genotoxic](Genotoxicity \"Genotoxicity\") tobacco smoke (e.g. [acrolein](Acrolein \"Acrolein\"), [formaldehyde](Formaldehyde \"Formaldehyde\"), [acrylonitrile](Acrylonitrile \"Acrylonitrile\"), [1,3-butadiene](1%2C3-Butadiene \"1,3-Butadiene\"), [acetaldehyde](Acetaldehyde \"Acetaldehyde\"), [ethylene oxide](Ethylene_oxide \"Ethylene oxide\") and [isoprene](Isoprene \"Isoprene\")).[18] [Endogenous (metabolically caused) DNA damage](DNA_damage_\\(naturally_occurring\\) \"DNA damage \\(naturally occurring\\)\") is also very frequent, occurring on average more than 60,000 times a day in the genomes of human cells. Externally and endogenously caused damages may be converted into mutations by inaccurate [translesion synthesis](Translesion_synthesis \"Translesion synthesis\") or inaccurate DNA repair (e.g. by [non-homologous end joining](Non-homologous_end_joining \"Non-homologous end joining\")). \n\n##### High frequency\n\nThe high frequency of mutations in the total genome within carcinomas suggests that, often, an early carcinogenic alteration may be a deficiency in DNA repair. For instance, mutation rates substantially increase (sometimes by 100-fold) in cells defective in [DNA mismatch repair](DNA_mismatch_repair \"DNA mismatch repair\").[19]\n\nA deficiency in DNA repair, itself, can allow DNA damages to accumulate, and error-prone [translesion synthesis](DNA_repair \"DNA repair\") past some of those damages may give rise to mutations. In addition, faulty repair of these accumulated DNA damages may give rise to [epigenetic alterations or epimutations](Epigenetics \"Epigenetics\"). While a mutation or epimutation in a DNA repair gene, itself, would not confer a selective advantage, such a repair defect may be carried along as a passenger in a cell when the cell acquires an additional mutation/epimutation that does provide a proliferative advantage. Such cells, with both proliferative advantages and one or more DNA repair defects (causing a very high mutation rate), likely give rise to the high frequency of total genome mutations seen in carcinomas. \n\n#### DNA repair\n\nIn somatic cells, deficiencies in DNA repair sometimes arise by mutations in DNA repair genes, but much more often are due to [epigenetic](Epigenetics \"Epigenetics\") reductions in expression of DNA repair genes. Thus, in a sequence of 113 colorectal carcinomas, only four had somatic missense mutations in the DNA repair gene _[MGMT](MGMT_\\(gene\\) \"MGMT \\(gene\\)\")_ , while the majority of these cancers had reduced MGMT protein expression due to methylation of the _MGMT_ promoter region.[20]\n# Carcinoma\n\n## Diagnosis\n\nDiagnosis of carcinoma typically begins with clinical evaluation, including history, physical examination, laboratory tests (such as complete blood count and tumor markers), and imaging studies (e.g., CT, MRI, PET scans) to identify suspicious lesions.[21] Carcinomas can be definitively diagnosed through [biopsy](Biopsy \"Biopsy\"), including [fine-needle aspiration](Fine-needle_aspiration \"Fine-needle aspiration\") (FNA), [core biopsy](Core_biopsy \"Core biopsy\"), or subtotal removal of a single node. Microscopic examination by a [pathologist](Pathologist \"Pathologist\") is then necessary to identify molecular, cellular, or tissue architectural characteristics of epithelial cells. \n\n### Staging\n\n[Staging](Cancer_staging \"Cancer staging\") of carcinoma refers to the process of combining physical/clinical examination, pathological review of cells and tissues, surgical techniques, laboratory tests, and imaging studies in a logical fashion to obtain information about the size of the neoplasm and the extent of its invasion and [metastasis](Metastasis \"Metastasis\"). Carcinoma stage is the variable that has been most consistently and tightly linked to the [prognosis](Prognosis \"Prognosis\") of the malignancy. \n\nCarcinomas are usually staged with Roman numerals. In most classifications, Stage I and Stage II carcinomas are confirmed when the tumor has been found to be small and/or to have spread to local structures only. Stage III carcinomas typically have been found to have spread to regional lymph nodes, tissues, and/or organ structures, while Stage IV tumors have already metastasized through the [blood](Blood \"Blood\") to distant sites, tissues, or organs. \n\nIn some types of carcinomas, Stage 0 carcinoma has been used to describe [carcinoma _in situ_](Carcinoma_in_situ \"Carcinoma in situ\"), and [occult](Occult \"Occult\") carcinomas detectable only via examination of [sputum](Sputum \"Sputum\") for malignant cells (in [lung carcinomas](Lung_cancer \"Lung cancer\")). \n\nIn more recent staging systems, substages (a, b, c) are becoming more commonly used to better define groups of patients with similar prognosis or treatment options. \n\nThe criteria for staging can differ dramatically based upon the organ system in which the tumor arises. For example, the colon[23] and bladder cancer[24] staging system relies on depth of invasion, staging of breast carcinoma is more dependent on the size of the tumor, and in renal carcinoma, staging is based on both the size of the tumor and the depth of the tumor invasion into the renal sinus. Carcinoma of the lung has a more complicated staging system, taking into account a number of size and anatomic variables.[25]\n\nThe UICC/AJCC [TNM](TNM_staging_system \"TNM staging system\") systems are most often used.[26] For some common tumors, however, classical staging methods (such as the [Dukes classification](Colorectal_cancer#Dukes_system \"Colorectal cancer\") for [colon cancer](Colon_cancer \"Colon cancer\")) are still used. \n\n### Grading\n\nGrading of carcinomas refers to the employment of criteria intended to semi-quantify the degree of cellular and tissue maturity seen in the transformed cells relative to the appearance of the normal parent epithelial tissue from which the carcinoma derives. \n\nGrading of carcinoma is most often done after a treating physician and/or surgeon obtains a sample of suspected tumor tissue using [surgical resection](Surgical_resection \"Surgical resection\"), needle or surgical [biopsy](Biopsy \"Biopsy\"), direct washing or brushing of tumor tissue, [sputum](Sputum \"Sputum\") [cytopathology](Cytopathology \"Cytopathology\"), etc. A [pathologist](Pathologist \"Pathologist\") then examines the tumor and its [stroma](Stroma_\\(animal_tissue\\) \"Stroma \\(animal tissue\\)\"), perhaps utilizing [staining](Staining \"Staining\"), [immunohistochemistry](Immunohistochemistry \"Immunohistochemistry\"), [flow cytometry](Flow_cytometry \"Flow cytometry\"), or other methods. Finally, the pathologist classifies the tumor semi-quantitatively into one of three or four grades, including: \n\n  * Grade 1, or well differentiated: there is a close, or very close, resemblance to the normal parent tissue, and the tumor cells are easily identified and classified as a particular malignant histological entity;\n  * Grade 2, or moderately differentiated: there is considerable resemblance to the parent cells and tissues, but abnormalities can commonly be seen and the more complex features are not particularly well-formed;\n  * Grade 3, or poorly differentiated: there is very little resemblance between the malignant tissue and the normal parent tissue, abnormalities are evident, and the more complex architectural features are usually rudimentary or primitive;\n  * Grade 4, or undifferentiated carcinoma: these carcinomas bear no significant resemblance to the corresponding parent cells and tissues, with no visible formation of glands, ducts, bridges, stratified layers, keratin pearls, or other notable characteristics consistent with a more highly differentiated neoplasm.\n\nAlthough there is definite and convincing statistical [correlation](Correlation \"Correlation\") between carcinoma grade and tumor prognosis for some tumor types and sites of origin, the strength of this association can be highly variable. It may be stated generally, however, that the higher the grade of the lesion, the worse is its prognosis.[27][28]\n## Epidemiology\n\nCarcinomas account for approximately 80-90% of all human cancers, making them the most common type of malignancy.[5] In 2020, there were an estimated 10 million new cases of carcinoma worldwide, with the majority occurring in adults over 50 years of age. [](https://gco.iarc.who.int/media/globocan/factsheets/cancers/30-31-39-multiple-myeloma-globocan-2022.pdf) In the United States, about 1.7 million of the 1.9 million annual cancer diagnoses as of 2025 are carcinomas. [](https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2025-cancer-facts-figures.html) Incidence rates vary by type and region, with higher rates in developed countries due to aging populations and lifestyle factors.\n\nWhile cancer is generally considered a disease of old age, children can also develop cancer. In contrast to adults, carcinomas are exceptionally rare in children, comprising about 5% of pediatric cancers and less than 0.1% of all carcinoma diagnoses. [](https://www.cancer.gov/types/childhood-cancers/child-adolescent-cancers-fact-sheet) Approximately 9,550 children under age 20 in the US are diagnosed with cancer annually as of 2025, with only a few hundred being carcinomas. [](https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2025-cancer-facts-figures.html)\n\nMajor risk factors for carcinomas include advanced age, tobacco use, obesity, and environmental exposures, though these vary by subtype. For ovarian carcinoma specifically, age (most common over 55) and family history (including BRCA mutations) are among the primary risk factors. [](https://www.cancer.org/cancer/types/ovarian-cancer/causes-risks-prevention/risk-factors.html)"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761884067092,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"** Kirkham N, Lemoine NR (2001). [_Progress in pathology_](https://books.google.com/books?id=xiHcyr-BHeQC\u0026pg=PT61). London: Greenwich Medical Media. p. 52\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 9781841100500.\",\"description\":\"1. **^** Kirkham N, Lemoine NR (2001). [_Progress in pathology_](https://books.google.com/books?id=xiHcyr-BHeQC\u0026pg=PT61). London: Greenwich Medical Media. p. 52\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 9781841100500.\",\"url\":\"https://books.google.com/books?id=xiHcyr-BHeQC\u0026pg=PT61\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"** Weinberg RA (24 May 2013). _The biology of cancer_ (Second ed.). New York. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 9780815345282. [OCLC](OCLC_\\\\(identifier\\\\) \\\"OCLC \\\\(identifier\\\\)\\\") [841051175](https://search.worldcat.org/oclc/841051175).`{{cite book}}`: CS1 maint: location missing publisher (link)\",\"description\":\"2. **^** Weinberg RA (24 May 2013). _The biology of cancer_ (Second ed.). New York. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 9780815345282. [OCLC](OCLC_\\\\(identifier\\\\) \\\"OCLC \\\\(identifier\\\\)\\\") [841051175](https://search.worldcat.org/oclc/841051175).`{{cite book}}`: CS1 maint: location missing publisher (link)\",\"url\":\"ISBN_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"** [\\\"Definition of Carcinoma\\\"](https://web.archive.org/web/20121010214950/http://www.medterms.com/script/main/art.asp?articlekey=20677). Archived from [the original](http://www.medterms.com/script/main/art.asp?articlekey=20677) on 10 October 2012. Retrieved 27 January 2014.\",\"description\":\"3. **^** [\\\"Definition of Carcinoma\\\"](https://web.archive.org/web/20121010214950/http://www.medterms.com/script/main/art.asp?articlekey=20677). Archived from [the original](http://www.medterms.com/script/main/art.asp?articlekey=20677) on 10 October 2012. Retrieved 27 January 2014.\",\"url\":\"https://web.archive.org/web/20121010214950/http://www.medterms.com/script/main/art.asp?articlekey=20677\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"** _[Oxford English Dictionary](Oxford_English_Dictionary \\\"Oxford English Dictionary\\\"), 3rd edition, [](http://www.oed.com/view/Entry/27823)_[s.v.__](http://www.oed.com/view/Entry/27823)\",\"description\":\"4. **^** _[Oxford English Dictionary](Oxford_English_Dictionary \\\"Oxford English Dictionary\\\"), 3rd edition, [](http://www.oed.com/view/Entry/27823)_[s.v.__](http://www.oed.com/view/Entry/27823)\",\"url\":\"Oxford_English_Dictionary \\\"Oxford English Dictionary\\\"\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"_**a**_ _**b**_ _**c**_ Berman JJ (March 2004). [\\\"Tumor classification: molecular analysis meets Aristotle\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC415552). _BMC Cancer_. **4** (1): 10. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1186/1471-2407-4-10](https://doi.org/10.1186%2F1471-2407-4-10). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [415552](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC415552). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15113444](https://pubmed.ncbi.nlm.nih.gov/15113444).\",\"description\":\"5. ^ _**a**_ _**b**_ _**c**_ Berman JJ (March 2004). [\\\"Tumor classification: molecular analysis meets Aristotle\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC415552). _BMC Cancer_. **4** (1): 10. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1186/1471-2407-4-10](https://doi.org/10.1186%2F1471-2407-4-10). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [415552](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC415552). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15113444](https://pubmed.ncbi.nlm.nih.gov/15113444).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC415552\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"_**a**_ _**b**_ _**c**_ Berman JJ (November 2004). [\\\"Tumor taxonomy for the developmental lineage classification of neoplasms\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535937). _BMC Cancer_. **4** (1): 88. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1186/1471-2407-4-88](https://doi.org/10.1186%2F1471-2407-4-88). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [535937](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535937). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15571625](https://pubmed.ncbi.nlm.nih.gov/15571625).\",\"description\":\"6. ^ _**a**_ _**b**_ _**c**_ Berman JJ (November 2004). [\\\"Tumor taxonomy for the developmental lineage classification of neoplasms\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535937). _BMC Cancer_. **4** (1): 88. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1186/1471-2407-4-88](https://doi.org/10.1186%2F1471-2407-4-88). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [535937](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535937). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15571625](https://pubmed.ncbi.nlm.nih.gov/15571625).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535937\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"** Image by Mikael Häggström, MD. Source for findings: Caroline I.M. Underwood, M.D., Carolyn Glass, M.D., Ph.D. [\\\"Lung - Small cell carcinoma\\\"](https://www.pathologyoutlines.com/topic/lungtumorsmallcell.html). _Pathology Outlines_.`{{cite web}}`: CS1 maint: multiple names: authors list (link) Last author update: 20 September 2022\",\"description\":\"7. **^** Image by Mikael Häggström, MD. Source for findings: Caroline I.M. Underwood, M.D., Carolyn Glass, M.D., Ph.D. [\\\"Lung - Small cell carcinoma\\\"](https://www.pathologyoutlines.com/topic/lungtumorsmallcell.html). _Pathology Outlines_.`{{cite web}}`: CS1 maint: multiple names: authors list (link) Last author update: 20 September 2022\",\"url\":\"https://www.pathologyoutlines.com/topic/lungtumorsmallcell.html\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"_**a**_ _**b**_ Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, eds. (2004). [_Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart_](https://web.archive.org/web/20090823210304/http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-cover.pdf) (PDF). World Health Organization Classification of Tumours. Lyon: IARC Press. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-92-832-2418-1. Archived from [the original](http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-cover.pdf) (PDF) on 23 August 2009. Retrieved 27 January 2014.\",\"description\":\"8. ^ _**a**_ _**b**_ Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, eds. (2004). [_Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart_](https://web.archive.org/web/20090823210304/http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-cover.pdf) (PDF). World Health Organization Classification of Tumours. Lyon: IARC Press. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-92-832-2418-1. Archived from [the original](http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-cover.pdf) (PDF) on 23 August 2009. Retrieved 27 January 2014.\",\"url\":\"https://web.archive.org/web/20090823210304/http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-cover.pdf\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"** Image by Mikael Häggström, MD. More info at [image description page in Wikimedia Commons](https://commons.wikimedia.org/wiki/File:CK7_and_CK20_by_body_location.svg \\\"commons:File:CK7 and CK20 by body location.svg\\\").\",\"description\":\"9. **^** Image by Mikael Häggström, MD. More info at [image description page in Wikimedia Commons](https://commons.wikimedia.org/wiki/File:CK7_and_CK20_by_body_location.svg \\\"commons:File:CK7 and CK20 by body location.svg\\\").\",\"url\":\"https://commons.wikimedia.org/wiki/File:CK7_and_CK20_by_body_location.svg \\\"commons:File:CK7 and CK20 by body location.svg\\\"\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"** Chang A (2007). [_Oncology: An Evidence-Based Approach_](https://books.google.com/books?id=vxh6u1-ETk0C\u0026pg=PA162). Springer. p. 162\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 9780387310565.\",\"description\":\"10. **^** Chang A (2007). [_Oncology: An Evidence-Based Approach_](https://books.google.com/books?id=vxh6u1-ETk0C\u0026pg=PA162). Springer. p. 162\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 9780387310565.\",\"url\":\"https://books.google.com/books?id=vxh6u1-ETk0C\u0026pg=PA162\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"** Looijenga LH, Hersmus R, de Leeuw BH, Stoop H, Cools M, Oosterhuis JW, et al. (April 2010). \\\"Gonadal tumours and DSD\\\". _Best Practice \u0026 Research. Clinical Endocrinology \u0026 Metabolism_. **24** (2): 291–310\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.beem.2009.10.002](https://doi.org/10.1016%2Fj.beem.2009.10.002). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20541153](https://pubmed.ncbi.nlm.nih.gov/20541153).\",\"description\":\"11. **^** Looijenga LH, Hersmus R, de Leeuw BH, Stoop H, Cools M, Oosterhuis JW, et al. (April 2010). \\\"Gonadal tumours and DSD\\\". _Best Practice \u0026 Research. Clinical Endocrinology \u0026 Metabolism_. **24** (2): 291–310\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.beem.2009.10.002](https://doi.org/10.1016%2Fj.beem.2009.10.002). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20541153](https://pubmed.ncbi.nlm.nih.gov/20541153).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"** \\\"Carcinoma\\\". Academic Press Dictionary of Science and Technology. `{{cite journal}}`: Cite journal requires `|journal=` (help)\",\"description\":\"12. **^** \\\"Carcinoma\\\". Academic Press Dictionary of Science and Technology. `{{cite journal}}`: Cite journal requires `|journal=` (help)\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"_**a**_ _**b**_ Vassilev A, DePamphilis ML (January 2017). [\\\"Links between DNA Replication, Stem Cells and Cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333035). _Genes_. **8** (2): 45. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3390/genes8020045](https://doi.org/10.3390%2Fgenes8020045). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5333035](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333035). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28125050](https://pubmed.ncbi.nlm.nih.gov/28125050).\",\"description\":\"13. ^ _**a**_ _**b**_ Vassilev A, DePamphilis ML (January 2017). [\\\"Links between DNA Replication, Stem Cells and Cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333035). _Genes_. **8** (2): 45. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3390/genes8020045](https://doi.org/10.3390%2Fgenes8020045). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5333035](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333035). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28125050](https://pubmed.ncbi.nlm.nih.gov/28125050).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333035\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"** Anandakrishnan R, Varghese RT, Kinney NA, Garner HR (March 2019). [\\\"Estimating the number of genetic mutations (hits) required for carcinogenesis based on the distribution of somatic mutations\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424461). _PLOS Computational Biology_. **15** (3): e1006881. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2019PLSCB..15E6881A](https://ui.adsabs.harvard.edu/abs/2019PLSCB..15E6881A). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1371/journal.pcbi.1006881](https://doi.org/10.1371%2Fjournal.pcbi.1006881). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6424461](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424461). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30845172](https://pubmed.ncbi.nlm.nih.gov/30845172).\",\"description\":\"14. **^** Anandakrishnan R, Varghese RT, Kinney NA, Garner HR (March 2019). [\\\"Estimating the number of genetic mutations (hits) required for carcinogenesis based on the distribution of somatic mutations\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424461). _PLOS Computational Biology_. **15** (3): e1006881. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2019PLSCB..15E6881A](https://ui.adsabs.harvard.edu/abs/2019PLSCB..15E6881A). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1371/journal.pcbi.1006881](https://doi.org/10.1371%2Fjournal.pcbi.1006881). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6424461](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424461). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30845172](https://pubmed.ncbi.nlm.nih.gov/30845172).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424461\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"** James, William; Berger, Timothy; Elston, Dirk (2005). _Andrews' Diseases of the Skin: Clinical Dermatology_. (10th ed.). Saunders. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 0-7216-2921-0.\",\"description\":\"15. **^** James, William; Berger, Timothy; Elston, Dirk (2005). _Andrews' Diseases of the Skin: Clinical Dermatology_. (10th ed.). Saunders. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 0-7216-2921-0.\",\"url\":\"ISBN_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"** Roach JC, Glusman G, Smit AF, Huff CD, Hubley R, Shannon PT, et al. (April 2010). [\\\"Analysis of genetic inheritance in a family quartet by whole-genome sequencing\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037280). _Science_. **328** (5978): 636–639\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2010Sci...328..636R](https://ui.adsabs.harvard.edu/abs/2010Sci...328..636R). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.1186802](https://doi.org/10.1126%2Fscience.1186802). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3037280](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037280). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20220176](https://pubmed.ncbi.nlm.nih.gov/20220176).\",\"description\":\"16. **^** Roach JC, Glusman G, Smit AF, Huff CD, Hubley R, Shannon PT, et al. (April 2010). [\\\"Analysis of genetic inheritance in a family quartet by whole-genome sequencing\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037280). _Science_. **328** (5978): 636–639\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2010Sci...328..636R](https://ui.adsabs.harvard.edu/abs/2010Sci...328..636R). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.1186802](https://doi.org/10.1126%2Fscience.1186802). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3037280](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037280). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20220176](https://pubmed.ncbi.nlm.nih.gov/20220176).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037280\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"** Tuna M, Amos CI (November 2013). [\\\"Genomic sequencing in cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622788). _Cancer Letters_. **340** (2): 161–170\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.canlet.2012.11.004](https://doi.org/10.1016%2Fj.canlet.2012.11.004). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3622788](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622788). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23178448](https://pubmed.ncbi.nlm.nih.gov/23178448).\",\"description\":\"17. **^** Tuna M, Amos CI (November 2013). [\\\"Genomic sequencing in cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622788). _Cancer Letters_. **340** (2): 161–170\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.canlet.2012.11.004](https://doi.org/10.1016%2Fj.canlet.2012.11.004). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3622788](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622788). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23178448](https://pubmed.ncbi.nlm.nih.gov/23178448).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622788\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"** Cunningham FH, Fiebelkorn S, Johnson M, Meredith C (November 2011). \\\"A novel application of the Margin of Exposure approach: segregation of tobacco smoke toxicants\\\". _Food and Chemical Toxicology_. **49** (11): 2921–2933\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.fct.2011.07.019](https://doi.org/10.1016%2Fj.fct.2011.07.019). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21802474](https://pubmed.ncbi.nlm.nih.gov/21802474).\",\"description\":\"18. **^** Cunningham FH, Fiebelkorn S, Johnson M, Meredith C (November 2011). \\\"A novel application of the Margin of Exposure approach: segregation of tobacco smoke toxicants\\\". _Food and Chemical Toxicology_. **49** (11): 2921–2933\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.fct.2011.07.019](https://doi.org/10.1016%2Fj.fct.2011.07.019). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21802474](https://pubmed.ncbi.nlm.nih.gov/21802474).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"** Hegan DC, Narayanan L, Jirik FR, Edelmann W, Liskay RM, Glazer PM (December 2006). [\\\"Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612936). _Carcinogenesis_. **27** (12): 2402–2408\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/carcin/bgl079](https://doi.org/10.1093%2Fcarcin%2Fbgl079). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2612936](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612936). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16728433](https://pubmed.ncbi.nlm.nih.gov/16728433).\",\"description\":\"19. **^** Hegan DC, Narayanan L, Jirik FR, Edelmann W, Liskay RM, Glazer PM (December 2006). [\\\"Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612936). _Carcinogenesis_. **27** (12): 2402–2408\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/carcin/bgl079](https://doi.org/10.1093%2Fcarcin%2Fbgl079). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2612936](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612936). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16728433](https://pubmed.ncbi.nlm.nih.gov/16728433).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612936\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"** Halford S, Rowan A, Sawyer E, Talbot I, Tomlinson I (June 2005). [\\\"O(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C\u003eA:T transitions\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774551). _Gut_. **54** (6): 797–802\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/gut.2004.059535](https://doi.org/10.1136%2Fgut.2004.059535). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1774551](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774551). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15888787](https://pubmed.ncbi.nlm.nih.gov/15888787).\",\"description\":\"20. **^** Halford S, Rowan A, Sawyer E, Talbot I, Tomlinson I (June 2005). [\\\"O(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C\u003eA:T transitions\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774551). _Gut_. **54** (6): 797–802\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/gut.2004.059535](https://doi.org/10.1136%2Fgut.2004.059535). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1774551](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774551). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15888787](https://pubmed.ncbi.nlm.nih.gov/15888787).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774551\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"** Wagman LD (2008). [\\\"Principles of Surgical Oncology\\\"](https://web.archive.org/web/20131004224102/http://www.cancernetwork.com/cancer-management-11/). In Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (eds.). [_Cancer Management: A Multidisciplinary Approach_](http://www.cancernetwork.com/cancer-management-11/) (11th ed.). Archived from [the original](http://www.cancernetwork.com/cancer-management-11/chapter01/article/10165/1399286) on 4 October 2013. Retrieved 8 June 2009.\",\"description\":\"21. **^** Wagman LD (2008). [\\\"Principles of Surgical Oncology\\\"](https://web.archive.org/web/20131004224102/http://www.cancernetwork.com/cancer-management-11/). In Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (eds.). [_Cancer Management: A Multidisciplinary Approach_](http://www.cancernetwork.com/cancer-management-11/) (11th ed.). Archived from [the original](http://www.cancernetwork.com/cancer-management-11/chapter01/article/10165/1399286) on 4 October 2013. Retrieved 8 June 2009.\",\"url\":\"https://web.archive.org/web/20131004224102/http://www.cancernetwork.com/cancer-management-11/\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"** Boyraz G, Selcuk I, Yazıcıoğlu A, Tuncer ZS (September 2013). \\\"Ovarian carcinoma associated with endometriosis\\\". _European Journal of Obstetrics, Gynecology, and Reproductive Biology_. **170** (1): 211–213\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.ejogrb.2013.06.001](https://doi.org/10.1016%2Fj.ejogrb.2013.06.001). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23849309](https://pubmed.ncbi.nlm.nih.gov/23849309).\",\"description\":\"22. **^** Boyraz G, Selcuk I, Yazıcıoğlu A, Tuncer ZS (September 2013). \\\"Ovarian carcinoma associated with endometriosis\\\". _European Journal of Obstetrics, Gynecology, and Reproductive Biology_. **170** (1): 211–213\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.ejogrb.2013.06.001](https://doi.org/10.1016%2Fj.ejogrb.2013.06.001). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23849309](https://pubmed.ncbi.nlm.nih.gov/23849309).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"** Puppa G, Sonzogni A, Colombari R, Pelosi G (June 2010). \\\"TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues\\\". _Archives of Pathology \u0026 Laboratory Medicine_. **134** (6): 837–852\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.5858/134.6.837](https://doi.org/10.5858%2F134.6.837). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20524862](https://pubmed.ncbi.nlm.nih.gov/20524862).\",\"description\":\"23. **^** Puppa G, Sonzogni A, Colombari R, Pelosi G (June 2010). \\\"TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues\\\". _Archives of Pathology \u0026 Laboratory Medicine_. **134** (6): 837–852\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.5858/134.6.837](https://doi.org/10.5858%2F134.6.837). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20524862](https://pubmed.ncbi.nlm.nih.gov/20524862).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"24\",\"title\":\"** Sharir S (February 2006). \\\"Update on clinical and radiological staging and surveillance of bladder cancer\\\". _The Canadian Journal of Urology_. **13** (Suppl 1): 71–76\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16526987](https://pubmed.ncbi.nlm.nih.gov/16526987).\",\"description\":\"24. **^** Sharir S (February 2006). \\\"Update on clinical and radiological staging and surveillance of bladder cancer\\\". _The Canadian Journal of Urology_. **13** (Suppl 1): 71–76\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16526987](https://pubmed.ncbi.nlm.nih.gov/16526987).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"25\",\"title\":\"** Pepek JM, Chino JP, Marks LB, D'amico TA, Yoo DS, Onaitis MW, et al. (April 2011). [\\\"How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: A comparison of the TNM 6 and 7 systems\\\"](https://doi.org/10.1097%2FJTO.0b013e31821038c0). _Journal of Thoracic Oncology_. **6** (4): 757–761\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1097/JTO.0b013e31821038c0](https://doi.org/10.1097%2FJTO.0b013e31821038c0). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21325975](https://pubmed.ncbi.nlm.nih.gov/21325975). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [24598745](https://api.semanticscholar.org/CorpusID:24598745).\",\"description\":\"25. **^** Pepek JM, Chino JP, Marks LB, D'amico TA, Yoo DS, Onaitis MW, et al. (April 2011). [\\\"How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: A comparison of the TNM 6 and 7 systems\\\"](https://doi.org/10.1097%2FJTO.0b013e31821038c0). _Journal of Thoracic Oncology_. **6** (4): 757–761\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1097/JTO.0b013e31821038c0](https://doi.org/10.1097%2FJTO.0b013e31821038c0). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21325975](https://pubmed.ncbi.nlm.nih.gov/21325975). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [24598745](https://api.semanticscholar.org/CorpusID:24598745).\",\"url\":\"https://doi.org/10.1097%2FJTO.0b013e31821038c0\",\"favicon\":\"\"},{\"id\":\"26\",\"title\":\"** [\\\"What is Cancer Staging?\\\"](https://web.archive.org/web/20071025013538/http://cancerstaging.org/mission/whatis.html). Archived from [the original](http://www.cancerstaging.org/mission/whatis.html) on 25 October 2007. Retrieved 27 January 2014.\",\"description\":\"26. **^** [\\\"What is Cancer Staging?\\\"](https://web.archive.org/web/20071025013538/http://cancerstaging.org/mission/whatis.html). Archived from [the original](http://www.cancerstaging.org/mission/whatis.html) on 25 October 2007. Retrieved 27 January 2014.\",\"url\":\"https://web.archive.org/web/20071025013538/http://cancerstaging.org/mission/whatis.html\",\"favicon\":\"\"},{\"id\":\"27\",\"title\":\"** Sun Z, Aubry MC, Deschamps C, Marks RS, Okuno SH, Williams BA, et al. (May 2006). [\\\"Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases\\\"](https://doi.org/10.1016%2Fj.jtcvs.2005.12.057). _The Journal of Thoracic and Cardiovascular Surgery_. **131** (5): 1014–1020\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.jtcvs.2005.12.057](https://doi.org/10.1016%2Fj.jtcvs.2005.12.057). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16678584](https://pubmed.ncbi.nlm.nih.gov/16678584).\",\"description\":\"27. **^** Sun Z, Aubry MC, Deschamps C, Marks RS, Okuno SH, Williams BA, et al. (May 2006). [\\\"Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases\\\"](https://doi.org/10.1016%2Fj.jtcvs.2005.12.057). _The Journal of Thoracic and Cardiovascular Surgery_. **131** (5): 1014–1020\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.jtcvs.2005.12.057](https://doi.org/10.1016%2Fj.jtcvs.2005.12.057). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16678584](https://pubmed.ncbi.nlm.nih.gov/16678584).\",\"url\":\"https://doi.org/10.1016%2Fj.jtcvs.2005.12.057\",\"favicon\":\"\"},{\"id\":\"28\",\"title\":\"** [\\\"Poorly differentiated cancer from an unknown primary site\\\"](https://www.uptodate.com/contents/poorly-differentiated-cancer-from-an-unknown-primary-site). Retrieved 6 June 2022.\",\"description\":\"28. **^** [\\\"Poorly differentiated cancer from an unknown primary site\\\"](https://www.uptodate.com/contents/poorly-differentiated-cancer-from-an-unknown-primary-site). Retrieved 6 June 2022.\",\"url\":\"https://www.uptodate.com/contents/poorly-differentiated-cancer-from-an-unknown-primary-site\",\"favicon\":\"\"},{\"id\":\"29\",\"title\":\"** Kuriakose MA, Hicks WL, Loree TR, Yee H (August 2001). [\\\"Risk group-based management of differentiated thyroid carcinoma\\\"](https://web.archive.org/web/20100505055603/http://www.rcsed.ac.uk/journal/vol46_4/4640008.htm). _Journal of the Royal College of Surgeons of Edinburgh_. **46** (4): 216–223\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11523714](https://pubmed.ncbi.nlm.nih.gov/11523714). Archived from [the original](http://www.rcsed.ac.uk/journal/vol46_4/4640008.htm) on 5 May 2010.\",\"description\":\"29. **^** Kuriakose MA, Hicks WL, Loree TR, Yee H (August 2001). [\\\"Risk group-based management of differentiated thyroid carcinoma\\\"](https://web.archive.org/web/20100505055603/http://www.rcsed.ac.uk/journal/vol46_4/4640008.htm). _Journal of the Royal College of Surgeons of Edinburgh_. **46** (4): 216–223\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11523714](https://pubmed.ncbi.nlm.nih.gov/11523714). Archived from [the original](http://www.rcsed.ac.uk/journal/vol46_4/4640008.htm) on 5 May 2010.\",\"url\":\"https://web.archive.org/web/20100505055603/http://www.rcsed.ac.uk/journal/vol46_4/4640008.htm\",\"favicon\":\"\"},{\"id\":\"30\",\"title\":\"** [\\\"Key Statistics for Childhood Cancers\\\"](https://www.cancer.org/cancer/cancer-in-children/key-statistics.html). _www.cancer.org_. Retrieved 6 May 2019.\",\"description\":\"30. **^** [\\\"Key Statistics for Childhood Cancers\\\"](https://www.cancer.org/cancer/cancer-in-children/key-statistics.html). _www.cancer.org_. Retrieved 6 May 2019.\",\"url\":\"https://www.cancer.org/cancer/cancer-in-children/key-statistics.html\",\"favicon\":\"\"},{\"id\":\"31\",\"title\":\"** Roett MA, Evans P (September 2009). [\\\"Ovarian cancer: an overview\\\"](https://www.aafp.org/afp/2009/0915/p609.html). _American Family Physician_. **80** (6): 609–16\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19817326](https://pubmed.ncbi.nlm.nih.gov/19817326).\",\"description\":\"31. **^** Roett MA, Evans P (September 2009). [\\\"Ovarian cancer: an overview\\\"](https://www.aafp.org/afp/2009/0915/p609.html). _American Family Physician_. **80** (6): 609–16\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19817326](https://pubmed.ncbi.nlm.nih.gov/19817326).\",\"url\":\"https://www.aafp.org/afp/2009/0915/p609.html\",\"favicon\":\"\"}],\"images\":[],\"fixedIssues\":[{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"\\\"and that arises from cells originating in the [endodermal](Endoderm \\\"Endoderm\\\"), [mesodermal](Mesoderm \\\"Mesoderm\\\")[2] or [ectodermal](Ectoderm \\\"Ectoderm\\\") [germ layer](Germ_layer \\\"Germ layer\\\") during [embryogenesis](Embryogenesis \\\"Embryogenesis\\\").[3]\\\"\",\"explanation\":\"Ref [3] (medterms.com) defines carcinoma as cancer beginning in cells lining an organ but does not mention germ layers or embryogenesis. The claim about germ layer origins is unsupported by [3]. Ref [2] is cited only for mesoderm, which is incomplete.\",\"fixedText\":\"Rephrase the sentence to properly cite [5] for the germ layer origin claim. Remove or adjust [2] and [3] placements.\",\"evidenceSource\":\"[5] Berman JJ (2004) discusses tumor classification by developmental lineage, including carcinomas from endodermal, ectodermal, and mesodermal origins.\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"\\\"Not to be confused with [carcinoid](Carcinoid \\\"Carcinoid\\\"), which is sometimes a type of carcinoma but is more often benign.\\\"\",\"explanation\":\"Carcinoid tumors are neuroendocrine tumors (NETs), a distinct category of epithelial neoplasms with neuroendocrine differentiation, not typically classified as carcinomas. Carcinomas generally refer to non-neuroendocrine epithelial malignancies. This misclassifies carcinoids.\",\"fixedText\":\"Remove the entire disambiguation sentence due to factual inaccuracy.\",\"evidenceSource\":\"NCBI/PMC articles and WHO classifications describe carcinoids as NETs, separate from standard carcinomas (e.g., neuroendocrine carcinomas are high-grade subtypes, but classic carcinoids are low-grade NETs).\"},{\"criticality\":\"Critical\",\"issueType\":\"Figures/Tables/Data Presentation\",\"problematicText\":\"\\\"Carcinoma  \\n---  \\n![](./_assets_/Small_cell_lung_cancer_-_cytology.jpg)  \\n[Micrograph](Micrograph \\\"Micrograph\\\") of a [lung primary](Lung_cancer \\\"Lung cancer\\\") [small cell carcinoma](Small_cell_carcinoma \\\"Small cell carcinoma\\\"), a type of carcinoma. The clustered cancerous cells consist primarily of nucleus (purple); they have only a scant rim of [cytoplasm](Cytoplasm \\\"Cytoplasm\\\"). The surrounding pale staining, discoid cells are [red blood cells](Red_blood_cells \\\"Red blood cells\\\"). [Cytopathology](Cytopathology \\\"Cytopathology\\\") specimen. [Field stain](Field_stain \\\"Field stain\\\").  \\n[Specialty](Medical_specialty \\\"Medical specialty\\\")| [Oncology](Oncology \\\"Oncology\\\")\\\"\",\"explanation\":\"The section contains a malformed infobox/table structure that incorrectly presents the specialty information alongside the image caption, potentially confusing readers. The table format is invalid and mixes content improperly.\",\"fixedText\":\"Remove the table structure (\\\"Carcinoma ---\\\" and \\\"Specialty| Oncology\\\"). Retain the image and its caption as standalone. The specialty can be inferred from context or covered elsewhere if needed.\",\"evidenceSource\":\"N/A (formatting issue)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"N/A\",\"explanation\":\"The introduction lacks mention that carcinomas are the most common type of human cancer, accounting for 80-90% of cases, which is a key definitional fact for scope and significance.\",\"fixedText\":\"Add: \\\"Carcinomas represent about 80-90% of all cancers.\\\" with appropriate citation.\",\"evidenceSource\":\"Cleveland Clinic: \\\"Carcinoma is the most common type of cancer, accounting for 80% to 90% of all cancer diagnoses.\\\"\"},{\"criticality\":\"Critical\",\"issueType\":\"Mechanism/Specification Error\",\"problematicText\":\"### ICD-10 code\",\"explanation\":\"The listed codes (e.g., 8010-8045, M8070/3) are morphology codes from the International Classification of Diseases for Oncology (ICD-O), specifically ICD-O-3, used for histological typing of neoplasms in cancer registries. ICD-10 is a separate system for classifying diseases generally, using codes like C00-C96 for malignant neoplasms but without detailed morphology. This mislabeling inaccurately represents the coding standard for oncology classification.\",\"fixedText\":\"Change the heading to \\\"### ICD-O morphology codes\\\" and add a citation to the official ICD-O documentation after the list, e.g., \\\"These are morphology codes from ICD-O-3.2.[](https://seer.cancer.gov/icd-o-3/)\\\"\",\"evidenceSource\":\"[](https://seer.cancer.gov/icd-o-3/)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"As of 2004, no simple and comprehensive classification system has been devised and accepted within the scientific community.[5]\",\"explanation\":\"The statement is dated to 2004 and does not acknowledge subsequent developments in tumor classification, such as the WHO Classification of Tumours (5th edition, 2019–2021), which provides organ-specific comprehensive classifications incorporating histological, molecular, and genetic features for carcinomas. This gap leaves readers without current context on accepted standards.\",\"fixedText\":\"Add after the sentence: \\\"Subsequent developments include the World Health Organization's (WHO) Classification of Tumours series (5th edition, ongoing since 2019), which offers detailed, site-specific classifications integrating histological and molecular criteria.[](https://tumourclassification.iarc.who.int/)\\\"\",\"evidenceSource\":\"[](https://tumourclassification.iarc.who.int/)\"},{\"criticality\":\"Critical\",\"issueType\":\"Mechanism/Specification Error\",\"problematicText\":\"A progenitor carcinoma stem cell can be formed from any of a number of oncogenic combinations of mutations in a totipotent cell,[13]\",\"explanation\":\"Totipotent cells exist only in the early embryo (e.g., zygote) and can differentiate into all cell types, including extraembryonic tissues. Carcinomas, being epithelial malignancies, typically originate from adult tissue-specific stem, progenitor, or differentiated epithelial cells, not totipotent cells. This misstates the developmental origin and is unsupported by standard oncology.\",\"fixedText\":\"Remove reference to totipotent cells; revise to emphasize origins from multipotent progenitor or differentiated epithelial cells, retaining citations [13] and [14] where applicable.\",\"evidenceSource\":\"Ref [13]; general oncology knowledge from sources like NCI and reviews on cancer stem cell origins.\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Metastatic carcinoma is cancer that is able to grow at sites distant from the primary site of origin; thus, dissemination to the skin may occur with any malignant neoplasm, and these infiltrates may result from direct invasion of the skin from underlying tumors, may extend by lymphatic or hematogenous spread, or may be introduced by therapeutic procedures.[15]: 628–9\",\"explanation\":\"Reference [15] is from a dermatology textbook (Andrews' Diseases of the Skin) discussing skin-specific metastases. The text presents this as a general definition of metastatic carcinoma, creating a mismatch where site-specific content is applied broadly, misleading on the general mechanisms of metastasis in carcinomas.\",\"fixedText\":\"Remove skin-specific details and citation [15]; rewrite for a general definition of metastatic carcinoma with spread via lymph or blood, citing an authoritative general source like NCI.\",\"evidenceSource\":\"[15] James et al. (2005), Andrews' Diseases of the Skin.\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Ovaries: One of the most deadly forms due to late detection.[22]\",\"explanation\":\"Reference [22] discusses the association between ovarian carcinoma and endometriosis but does not address mortality rates or reasons for late detection, such as advanced stage at diagnosis.\",\"fixedText\":\"Replace citation [22] with a source that supports the claim of high mortality due to late-stage diagnosis, such as American Cancer Society data showing 75% of cases diagnosed at advanced stages with lower survival rates.\",\"evidenceSource\":\"[](https://www.cancer.org/cancer/types/ovarian-cancer/detection-diagnosis-staging/survival-rates.html)\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"### Types\\n\\n  * Oral: Most oral cancers are [squamous-cell carcinoma](Squamous-cell_carcinoma \\\"Squamous-cell carcinoma\\\")\\n  * Lung: Carcinoma comprises \u003e98% of all [lung cancers](Lung_cancer \\\"Lung cancer\\\").\\n  * Breast: Nearly all breast cancers are [ductal carcinoma](Ductal_carcinoma \\\"Ductal carcinoma\\\").\\n  * Prostate: The most common form of [carcinoma of the prostate](Prostate_cancer \\\"Prostate cancer\\\") is adenocarcinoma.\\n  * Colon and rectum: Nearly all malignancies of the colon and rectum are either adenocarcinoma or squamous cell carcinoma.\\n  * Pancreas: Pancreatic carcinoma is almost always of the adenocarcinoma type and is highly lethal.\\n  * Ovaries: One of the most deadly forms due to late detection.[22]\\n\\nSome carcinomas are named for their or the putative cell of origin, (e.g.[hepatocellular carcinoma](Hepatocellular_carcinoma \\\"Hepatocellular carcinoma\\\"), [renal cell carcinoma](Renal_cell_carcinoma \\\"Renal cell carcinoma\\\")).\",\"explanation\":\"This subsection describes histological classification of carcinomas by organ site, which duplicates content intended for the \\\"Classification \u003e Histological types\\\" section per the article structure. It misrepresents as \\\"Types\\\" under Diagnosis, confusing readers about diagnostic methods versus cancer subtypes.\",\"fixedText\":\"Remove the subsection to avoid duplication, as histological types are covered elsewhere. If retaining, rewrite to focus on site-specific diagnostic approaches (e.g., biopsy types, imaging) to align with Diagnosis.\",\"evidenceSource\":\"Article structure outline\"},{\"criticality\":\"Critical\",\"issueType\":\"Mechanism/Specification Error\",\"problematicText\":\"Colon and rectum: Nearly all malignancies of the colon and rectum are either adenocarcinoma or squamous cell carcinoma.\",\"explanation\":\"Squamous cell carcinoma accounts for only 0.1-0.5% of colorectal cancers, making it negligible; nearly all (95%) are adenocarcinomas. This inaccurately presents squamous as a significant type, misleading on disease specification.\",\"fixedText\":\"Correct to: \\\"Nearly all malignancies of the colon and rectum are adenocarcinomas.\\\"\",\"evidenceSource\":\"[](https://www.cancercenter.com/cancer-types/colorectal-cancer/types)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"Carcinomas can be definitively diagnosed through [biopsy](Biopsy \\\"Biopsy\\\"), including [fine-needle aspiration](Fine-needle_aspiration \\\"Fine-needle aspiration\\\") (FNA), [core biopsy](Core_biopsy \\\"Core biopsy\\\"), or subtotal removal of single node,.[21] Microscopic examination by a [pathologist](Pathologist \\\"Pathologist\\\") is then necessary to identify molecular, cellular, or tissue architectural characteristics of epithelial cells.\",\"explanation\":\"The description focuses solely on biopsy for definitive diagnosis but omits common initial diagnostic steps like imaging (CT, MRI, PET) and laboratory tests (tumor markers, blood chemistry), which are essential for suspecting carcinoma and guiding biopsy, per standard oncology protocols.\",\"fixedText\":\"Add mention of imaging and lab tests as preliminary steps before biopsy to complete the diagnostic process overview.\",\"evidenceSource\":\"[](https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"While cancer is generally considered a disease of old age, children can also develop cancer.[29]\",\"explanation\":\"Reference [29] discusses risk groups for differentiated thyroid carcinoma in adults, not childhood cancer incidence or general statements about cancer in children. This mismatches the claim, undermining verifiability per Wikipedia guidelines.\",\"fixedText\":\"Remove or replace citation [29] with an appropriate source, such as American Cancer Society statistics on childhood cancer.\",\"evidenceSource\":\"[29] Kuriakose MA et al. (2001). Journal of the Royal College of Surgeons of Edinburgh.\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Less than 1% of carcinoma diagnoses are in children.[30]\",\"explanation\":\"Reference [30] provides key statistics for childhood cancers overall but does not specifically address the percentage of carcinoma diagnoses occurring in children. This is a mismatch; the claim is factually approximate (actual ~0.03-0.05% based on US data) but not supported by the cited source.\",\"fixedText\":\"Replace citation [30] with a source that directly supports the percentage, e.g., NCI fact sheet on childhood cancers, or rephrase to cite general rarity without specific percentage if unsourced.\",\"evidenceSource\":\"[30] American Cancer Society. Key Statistics for Childhood Cancers (2019). Current data from NCI/SEER indicate ~15,000 childhood cancers/year vs. ~1.5M carcinomas total, supporting low percentage but not the exact source.\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"The two biggest risk factors for ovarian carcinoma are age and family history.[31]\",\"explanation\":\"Reference [31] states family history/genetic syndromes as the greatest risk factor but does not explicitly list age and family history as the \\\"two biggest.\\\" Age is noted as increasing incidence but not ranked as top. This misrepresents the source.\",\"fixedText\":\"Rephrase to \\\"Major risk factors for ovarian carcinoma include age and family history\\\" and update citation to a current authoritative source like ACS (2025).\",\"evidenceSource\":\"[31] Roett MA, Evans P (2009). American Family Physician.\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"[Entire section lacks general epidemiology]\",\"explanation\":\"Epidemiology section for \\\"Carcinoma\\\" (80-90% of all cancers) omits key data: global/US incidence (~1.9M cases/year in US, mostly adults), prevalence, trends (stable/increasing), general risk factors (age, tobacco, obesity), and variations by type/region. Focus on children and ovarian is narrow/incomplete, leaving knowledge gaps on scope and impact.\",\"fixedText\":\"Add general statistics: Carcinomas account for ~80% of cancers; annual global incidence ~10M; primary risk factor is age (\u003e50). Include trends and common risks without duplicating other sections (e.g., specific types in Classification).\",\"evidenceSource\":\"ACS Cancer Facts \u0026 Figures 2025; WHO Global Cancer Observatory (as of 2022, updated 2025).\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"Less than 1% of carcinoma diagnoses are in children.[30] ... The two biggest risk factors for ovarian carcinoma are age and family history.[31]\",\"explanation\":\"Citations [30] (2019) and [31] (2009) are outdated as of 2025. Childhood cancer stats have updated (e.g., ~9,550 US diagnoses in 2025 per ACS); ovarian risk factors unchanged but sources should reflect current data for accuracy.\",\"fixedText\":\"Update to current sources with \\\"as of 2025\\\" where applicable; e.g., childhood carcinomas remain rare (~5% of pediatric cancers, \u003c0.1% of all carcinomas).\",\"evidenceSource\":\"ACS Cancer Facts \u0026 Figures 2025.\"}],\"slug\":\"Carcinoma\",\"title\":\"Carcinoma\",\"content\":\"$1f\",\"description\":\"Carcinoma\\n\\nCarcinoma is a malignancy that develops from epithelial cells.^[1] Specifically, a carcinoma is a cancer that begins in a tissue that lines the inner or outer surfaces of the body, and...\",\"metadata\":{\"categories\":[],\"lastModified\":\"1761553317\",\"contentLength\":\"20556\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"149128\",\"recentViews\":\"149128\",\"dailyAvgViews\":4970.93310546875,\"qualityScore\":1,\"lastViewed\":\"1761884066\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761884067089,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"Carcinoma\"],\"queryHash\":\"[\\\"page\\\",\\\"Carcinoma\\\"]\"}]},\"children\":\"$L20\"}]\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"Carcinoma\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"Carcinoma is a malignancy that develops from epithelial cells.^[1] Specifically, a carcinoma is a cancer that begins in a tissue that lines the inner or outer surfaces of the body, and that arises from cells originating in the endodermal, mesodermal or ectodermal germ layer during embryogenesis.^[5] Carcinomas represent 80-90% of all human cancers.^[48] It is from the Greek: καρκίνωμα, romanized: karkinōma, lit. 'sore, ulcer, cancer' (itself derived from karkinos meaning crab).^[4] As of 2004,...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"5\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"6\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/Carcinoma\"}],[\"$\",\"meta\",\"7\",{\"property\":\"og:title\",\"content\":\"Carcinoma\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:description\",\"content\":\"Carcinoma is a malignancy that develops from epithelial cells.^[1] Specifically, a carcinoma is a cancer that begins in a tissue that lines the inner or outer surfaces of the body, and that arises from cells originating in the endodermal, mesodermal or ectodermal germ layer during embryogenesis.^[5] Carcinomas represent 80-90% of all human cancers.^[48] It is from the Greek: καρκίνωμα, romanized: karkinōma, lit. 'sore, ulcer, cancer' (itself derived from karkinos meaning crab).^[4] As of 2004,...\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/Carcinoma\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:alt\",\"content\":\"Carcinoma\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"17\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:13.317Z\"}],[\"$\",\"meta\",\"18\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:title\",\"content\":\"Carcinoma\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:description\",\"content\":\"Carcinoma is a malignancy that develops from epithelial cells.^[1] Specifically, a carcinoma is a cancer that begins in a tissue that lines the inner or outer surfaces of the body, and that arises from cells originating in the endodermal, mesodermal or ectodermal germ layer during embryogenesis.^[5] Carcinomas represent 80-90% of all human cancers.^[48] It is from the Greek: καρκίνωμα, romanized: karkinōma, lit. 'sore, ulcer, cancer' (itself derived from karkinos meaning crab).^[4] As of 2004,...\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"23\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L21\",\"24\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"22:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"23:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="ZDIzMjY5MzItODQ4Zi00YzViLWFkZmMtNDE4ZGY1YWZkM2E1">self.__next_f.push([1,"20:[\"$\",\"$L22\",null,{\"children\":[\"$\",\"$L23\",null,{\"slug\":\"Carcinoma\"}]}]\n"])</script></body></html>